Back to top
more

Agilent Technologies (A)

(Delayed Data from NYSE)

$123.75 USD

123.75
1,475,965

+0.36 (0.29%)

Updated Sep 29, 2025 04:00 PM ET

After-Market: $123.78 +0.03 (0.02%) 6:34 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.64%
2Buy17.83%
3Hold9.69%
4Sell5.29%
5Strong Sell2.54%
S&P50011.29%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value D Growth F Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 39% (150 out of 245)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Santa Clara, CA-based Agilent Technologies, Inc. was originally a spin-off from Hewlett-Packard. The company is an original equipment manufacturer (OEM) of a broad-based portfolio of test and measurement products serving multiple end markets. The company has three business segments, including Life Sciences & Applied Markets Group (LSAG), Diagnostics and Genomics Group (DGG) and Agilent Cross Lab Group (ACG). The company uses a direct sales model for the distribution of its products, which is supplemented by distributors, resellers, manufacturers’ representatives, telesales and electronic commerce.

Zacks Equity Research

Will New Products, Expansion Aid GoDaddy (GDDY) Q2 Earnings?

by Zacks Equity Research

Increasing demand for GoDaddy's (GDDY) new products and international expansion might favor its Q2 results. However, rising competition is a concern.

    Zacks Equity Research

    Will Innovative Products Aid Fitbit's (FIT) Q2 Earnings?

    by Zacks Equity Research

    Fitbit's (FIT) focus on healthcare platforms might benefit its second-quarter results. However, intensifying competition in the wearables market remains a major concern.

      Zacks Equity Research

      Fortive (FTV) Beats on Q2 Earnings & Revenue Estimates

      by Zacks Equity Research

      Robust product portfolio and benefits from acquisitions drives Fortive's (FTV) second-quarter results.

        Zacks Equity Research

        Square (SQ) to Report Q2 Earnings: What's in the Cards?

        by Zacks Equity Research

        Square's (SQ) second-quarter 2018 results are likely to benefit from improving presence in bitcoin space and growing GPV. However, acquisition costs and issuance of notes remain headwinds.

          Zacks Equity Research

          Can Growing Partnerships Drive Baidu's (BIDU) Q2 Earnings?

          by Zacks Equity Research

          Strong product portfolio and growing partnerships will likely drive Baidu's (BIDU) second-quarter results.

            Zacks Equity Research

            MobileIron (MOBL) to Report Q2 Earnings: What's in Store?

            by Zacks Equity Research

            Strong product portfolio and growing partnerships will likely drive MobileIron's (MOBL) second-quarter results.

              Zacks Equity Research

              Will Amkor (AMKR) Q2 Earnings Gain From Strong Auto Demand?

              by Zacks Equity Research

              Healthy growth in the automotive business and acquisition-related benefits are going to drive Amkor's (AMKR) second-quarter results.

                Zacks Equity Research

                Fortive (FTV) to Report Q2 Earnings: What's in the Cards?

                by Zacks Equity Research

                Fortive's (FTV) second-quarter results are likely to benefit from expanding product portfolio and positive contributions from its strategic buyouts.

                  Zacks Equity Research

                  Mettler-Toledo (MTD) Q2 Earnings: Disappointment in Store?

                  by Zacks Equity Research

                  Mettler-Toledo's (MTD) second-quarter results are likely to benefit from robust laboratory business. However, weak product inspection business remains a concern.

                    Zacks Equity Research

                    What's in Store for Amphenol (APH) This Earnings Season?

                    by Zacks Equity Research

                    Amphenol (APH) is expected to benefit from organic and inorganic growth across most of its end markets in second-quarter 2018 results.

                      Zacks Equity Research

                      What's in the Cards for Waters Corp (WAT) in Q2 Earnings?

                      by Zacks Equity Research

                      Waters Corp (WAT) is scheduled to report second-quarter results which are likely to be driven by its strong position in the pharmaceutical market and robust mass spectrometry portfolio.

                        Zacks Equity Research

                        Agilent Acquires ULTRA Scientific Assets, Expands Portfolio

                        by Zacks Equity Research

                        Agilent (A) recently completes the buyout of the business assets of ULTRA Scientific, thereby expanding its already vast product portfolio.

                          Zacks Equity Research

                          Agilent (A) to Acquire ProZyme, Expand Glycan Market Share

                          by Zacks Equity Research

                          Agilent (A) agrees to acquire glycan analysis company ProZyme for an undisclosed amount.

                            Zacks Equity Research

                            Agilent (A) Opens Logistics Center, Expands China Foothold

                            by Zacks Equity Research

                            Agilent (A) opens a new logistics center in Shanghai to ensure timely delivery of its services in the country.

                              Zacks Equity Research

                              Agilent Technologies (A) Down 4.5% Since Earnings Report: Can It Rebound?

                              by Zacks Equity Research

                              Agilent Technologies (A) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

                                Zacks Equity Research

                                Agilent (A) Down 2.6% Since Earnings Report: Can It Rebound?

                                by Zacks Equity Research

                                Agilent (A) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

                                  Zacks Equity Research

                                  Agilent's AATI Acquisition to Strengthen Portfolio, Footprint

                                  by Zacks Equity Research

                                  Agilent (A) is set to acquire AATI, a developer of automated nucleic acid analysis systems using capillary electrophoresis methods, for $250 million.

                                    Zacks Equity Research

                                    Agilent (A) Q1 Earnings & Revenues Beat, '18 View Positive

                                    by Zacks Equity Research

                                    Agilent (A) first-quarter fiscal 2018 results benefit from robust top-line growth and improving end-market demand.

                                      Zacks Equity Research

                                      Is a Surprise Coming for Agilent Technologies (A) This Earnings Season?

                                      by Zacks Equity Research

                                      Agilent Technologies (A) is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat.

                                        Zacks Equity Research

                                        Agilent (A) Down 3.7% Since Earnings Report: Can It Rebound?

                                        by Zacks Equity Research

                                        Agilent (A) reported earnings about a month ago. What's next for the stock? We take a look at earnings estimates for some clues.

                                          Zacks Equity Research

                                          Itron Extends SMECO Contract, Offers Outsourced Solution

                                          by Zacks Equity Research

                                          Itron's (ITRI) contract extension with SMECO anticipated to drive bookings growth in the near term.

                                            Zacks Equity Research

                                            Itron (ITRI) Q3 Earnings & Revenues Lag on Shipment Delays

                                            by Zacks Equity Research

                                            Itron's (ITRI) top and bottom lines missed the Zacks Consensus Estimate in Q3 on shipment delays. The company updated its full-year 2017 guidance.

                                              Zacks Equity Research

                                              Teradyne (TER) in Focus: Stock Moves 7.4% Higher

                                              by Zacks Equity Research

                                              Teradyne (TER) was a big mover last session, as the company saw its shares rise more than 7% on the day.

                                                Zacks Equity Research

                                                Will Agilent Technologies (A) Crush Estimates at Its Next Earnings Report?

                                                by Zacks Equity Research

                                                Agilent Technologies (A) has seen a nice short-term history of beating earnings estimates, and looks poised to crush analyst expectations in its next earnings report as well.

                                                  Zacks Equity Research

                                                  Agilent Technologies (A) Up 10.6% Since Earnings Report: Can It Continue?

                                                  by Zacks Equity Research

                                                  Agilent Technologies (A) reported earnings about a month ago. What's next for the stock? We take a look at earnings estimates for some clues.